Naučne publikacije akademskog osoblja

Naučne publikacije i umetničke reference akademskog osoblja

Univerzitet u Nišu

NAPOMENA

Za tačnost unetih podataka o publikacijama, naučnim i umetničkim referencama odgovorni su autori.
Datum kreiranja: 29.08.2025.

Vladislav Volarević

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 09.09.1979
  • Mesto rođenja: Nis

  • Obrazovanje

  • Fakultet: Medicinski fakultet Niš
  • Odsek / Grupa / Smer: Medicina
  • Godina diplomiranja: 2006.

  • Spisak publikacija

  • Monografije i poglavlja u monografijama:

    1. Volarevic V and Lukic ML. Autoimmune Disorders in Galectin-3 Deficient Mice (pp 359-376) in Galectins and Disease Implications for Targeted Therapeutics, (edited by Anatole A. Klyosov, Peter G. Traber),  2012, ISBN13:9780841228801, American Chemical Society. M14
  • Knjige i udžbenici:

    1. Volarevic V, Gazdic Jankovic M. Imunologija trudnoce. (pp 343-361)  U: Biologija zenskog reproduktivnog sistema, urednika Radmile Kovačević, dr Nebojše Andrića, 2024; ISBN 978-86-7031-668-3.


    2. Volarevic V, Lako M, Stojkovic M. Mesenchymal Stem Cells for Diabetes and Related complications (chapter II: Clinical translation, pp 207-228) in Esentials of Mesenchymal Stem Cell biology and its clinical translation (edited by Robert Chuchua Zhao), 2013, ISBN 978-94-007-6715-7, Springer


     


    3. Arsenijevic N, Volarevic V, Milovanovic M, and Bugarcic ZD. Gold (III) complexes, cytotoxic effects (pp 922-927) in Encyclopedia of Metalloproteins (edited by Robert Kretsinger, Vladimir Uversky, Eugene Permyakov), 2013, ISBN 978-1-4614-1532-9, Springer


    4. Volarević V, Radosavljević G, Kanjevac T, Arsenijević N. Vrednovanje naučnika po kriterijumima Ministarstva nauke. U: Vrednovanje nauke i naučnika. Akademija medicinskih nauka srpskog lekarskog društva i Fakultet medicinskih nauka 2014; pp103-119 ISBN 978-86-7760-079-2


     


    5. Volarevic V, Jakovljevic J, Harrell CR, Fellabaum C, Arsenijevic N. The role of autophagy in mesenchymal stem cell- based suppression of immune response in Autophagy (pp 119-134) in Autophagy in Health and Disease Potential Therapeutic Approaches (edited by Kursad Turksen), 2018, ISBN 978-3-319-98145-1 (ISBN 978-3-319-98146-8 (eBook)), Humana press, Springer Nature Switzerland AG


     
  • Radovi u časopisima sa IMPACT faktorom:

    1.    Volarevic V, Harrell CR, Arsenijevic A, Djonov V, Volarevic A. Effects of Mesenchymal Stem Cells on Functions of Chimeric Antigen Receptor-Expressing T Lymphocytes and Natural Killer Cells. Cells. 2025 Jun 25;14(13):978. doi: 10.3390/cells14130978.  IF(5)=6.1. M21
    2.    Volarevic A, Harrell CR, Arsenijevic A, Djonov V, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Treatment of Parkinson's Disease. Cells. 2025 Apr 16;14(8):600. doi: 10.3390/cells14080600. IF(5)=6.1. M21
    3.    Volarevic V, Randall Harrell C, Arsenijevic A, Djonov V. An Interplay Between Pericytes, Mesenchymal Stem Cells, and Immune Cells in the Process of Tissue Regeneration. Anal Cell Pathol (Amst). 2025 Apr 9;2025:4845416. doi: 10.1155/ancp/4845416. 
    IF(5)=3.3 M21
    4.    Harrell CR, Volarevic A, Djonov V, Volarevic V*. Mesenchymal Stem-Cell-Derived Exosomes as Novel Drug Carriers in Anti-Cancer Treatment: A Myth or Reality? Cells. 2025 Jan 29;14(3):202. doi: 10.3390/cells14030202. IF(5)=6.1. M21
    5.    Randall Harrell C, Djonov V, Volarevic A, Arsenijevic A, Volarevic V*. Mesenchymal Stem Cell-Sourced Exosomes as Potentially Novel Remedies for Severe Dry Eye Disease. J Ophthalmol. 2025 Jan 10;2025:5552374. doi: 10.1155/joph/5552374. IF(5)=2.0 M22
    6.    Harrell CR, Volarevic A, Arsenijevic A, Djonov V, Volarevic V*. Targeted Therapy for Severe Sjogren's Syndrome: A Focus on Mesenchymal Stem Cells. Int J Mol Sci. 2024 Dec 22;25(24):13712. doi: 10.3390/ijms252413712. IF(5)=5.7 M21
    7.    Kastratovic N, Milosevic-Djordjevic O, Harrell CR, Djonov V, Volarevic V*. Effects of combustible cigarettes and electronic nicotine delivery systems on the regenerative properties of mesenchymal stem cells derived from periodontal ligament (PDL-MSCs). Histol Histopathol. 2024 Nov 27:18854. doi: 10.14670/HH-18-854. IF(5)=2.0 M22
    8.    Harrell CR, Volarevic V*. Ion Channels as Potential Drug Targets in Dry Eye Disease and Their Clinical Relevance: A Review. Cells. 2024 Dec 6;13(23):2017. doi: 10.3390/cells13232017. IF(5)=6.1. M21
    9.    Harrell CR, Djonov V, Volarevic A, Arsenijevic A, Volarevic V*. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Dependent Attenuation of Tear Hyperosmolarity and Immune Cell-Driven Inflammation in the Eyes of Patients with Dry Eye Disease. Diseases. 2024 Oct 26;12(11):269. doi: 10.3390/diseases12110269. IF(5)=3.4 M22
    10.    Trappetti V, Fernández-Palomo C, Arora P, Potez M, Pellicioli P, Fazzari J, Shintani N, Sanchez-Gonzalez I, Wu CT, de Breuyn Dietler B, Mercader-Huber N, Martin OA, von Gunten S, Volarevic V, Djonov V. Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams. Cancer Lett. 2025 Jan 1;608:217326. doi: 10.1016/j.canlet.2024.217326. IF(5)=9.5 M21a
    11.    Harrell CR, Volarevic A, Djonov V, Arsenijevic A, Volarevic V*. The Role of MicroRNAs in Mesenchymal Stem Cell-Based Modulation of Pulmonary Fibrosis. Cell Transplant. 2024 Jan-Dec; 33:9636897241281026. doi: 10.1177/09636897241281026. IF(5)=3.4 M21
    12.    Kastratovic N, Arsenijevic A, Harrell CR, Mladenovic V, Djukic A, Volarevic A, Jovanovic D, Zdravkovic M, Macut JB, Djonov V, Volarevic V*. Effects of combustible cigarettes and electronic nicotine delivery systems on immune cell-driven inflammation: Evidences from diabetic patients and multiple low dose streptozotocin-treated diabetic mice. J Biochem Mol Toxicol. 2024 Sep;38(9):e23841. doi: 10.1002/jbt.23841. IF(5)=3.1 M22
    13.    Kastratovic N, Markovic V, Arsenijevic A, Volarevic A, Zdravkovic N, Zdravkovic M, Brankovic M, Gmizic T, Harrell CR, Jakovljevic V, Djonov V, Volarevic V*. The effects of combustible cigarettes and electronic nicotine delivery systems on immune cell-driven inflammation and mucosal healing in ulcerative colitis. Nicotine Tob Res. 2024 Aug 5:ntae193. doi: 10.1093/ntr/ntae193. IF(5)=3.5 M21
    14.    Kastratovic N, Zdravkovic N, Cekerevac I, Sekerus V, Harrell CR, Mladenovic V, Djukic A, Volarevic A, Brankovic M, Gmizic T, Zdravkovic M, Bjekic-Macut J, Zdravkovic N, Djonov V, Volarevic V*. Effects of Combustible Cigarettes and Heated Tobacco Products on Systemic Inflammatory Response in Patients with Chronic Inflammatory Diseases. Diseases. 2024 Jul 5;12(7):144. doi: 10.3390/diseases12070144. IF(5)=3.4 M22
    15.    Kastratovic N, Cekerevac I, Sekerus V, Markovic V, Arsenijevic A, Volarevic A, Harrell CR, Jakovljevic V, Djonov V, Volarevic V*. Effects of combustible cigarettes and heated tobacco products on immune cell-driven inflammation in chronic obstructive respiratory diseases. Toxicol Sci. 2024:kfae068. doi: 10.1093/toxsci/kfae068. IF(5)=4.0 M21
    16.    Harrell CR, Djonov V, Volarevic A, Arsenijevic A, Volarevic V*. Molecular Mechanisms Responsible for the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Lung Fibrosis. Int J Mol Sci. 2024; 25(8):4378. doi: 10.3390/ijms25084378. IF(5)=5.7 M21
    17.    Bolli R, Ippolito L, Volarevic V. A tribute to Prof. Naranjan S. Dhalla, former Editor-in-Chief of Molecular and Cellular Biochemistry. Mol Cell Biochem. 2024 Sep;479(9):2163-2164. doi: 10.1007/s11010-024-05022-z. IF(5)=3.6 M22
    18.    Bolli R, Ippolito L, Volarevic V. A new era for Molecular and Cellular Biochemistry. Mol Cell Biochem. 2023 Nov;478(11):2405-2407. doi: 10.1007/s11010-023-04864-3. IF(5)=3.3 M22
    19.    Harrell CR, Feulner L, Djonov V, Pavlovic D, Volarevic V*. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients. Cells. 2023 Dec 1;12(23):2755. doi: 10.3390/cells12232755. IF(5)=6.0. M21
    20.    Kastratovic N, Markovic V, Harrell CR, Arsenijevic A, Stojanovic MD, Djonov V, Volarevic V*. Effects of combustible cigarettes and electronic nicotine delivery systems on the development and progression of chronic lung inflammation in mice. Nicotine Tob Res. 2024;26(6):704-714. doi: 10.1093/ntr/ntad235. IF(5)=3.5  M21
    21.    Harrell CR, Djonov V, Antonijevic A, Volarevic V*. NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases. Cells. 2023 Sep 21;12(18):2327. doi: 10.3390/cells12182327. IF(5)=6.0. M21
    22.    Pavlovic D, Miloradovic D, Stojanovic MD, Harrell CR, Polosa R, Rust S, Volti GL, Caruso M, Jakovljevic V, Djonov V, Volarevic V*. Cigarette smoke attenuates mesenchymal stem cell-based suppression of immune cell-driven acute liver failure. Toxicol Lett. 2023; 385:12-20. doi: 10.1016/j.toxlet.2023.08.006. IF(5)=3.2 M22
    23.    Harrell CR, Djonov V, Volarevic V*. Mesenchymal stem cell-derived microRNAs: Friends or foes of tumor cells? Histol Histopathol. 2023:18633. doi: 10.14670/HH-18-633. IF(5)=1.9 M22
    24.    Zdravkovic M, Harrell CR, Jakovljevic V, Djonov V, Volarevic V*. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Modulation of Obstructive Sleep Apnea. Int J Mol Sci. 2023; 24(4):3708. doi: 10.3390/ijms24043708. IF(5)=5.6 M21
    25.    Harrell CR, Djonov V, Volarevic V*. Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease. Int J Mol Sci. 2022 Oct 31;23(21):13254. doi: 10.3390/ijms232113254. IF(5)=6.2 M21
    26.    Harrell CR, Pavlovic D, Djonov V, Volarevic V*. Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure. World J Gastroenterol. 2022 Jul 28;28(28):3627-3636. doi: 10.3748/wjg.v28.i28.3627. IF(5)=5.3 M21
    27.    Trappetti V, Potez M, Fernandez-Palomo C, Volarevic V, Shintani N, Pellicioli P, Ernst A, Haberthür D, Fazzari JM, Krisch M, Laissue JA, Anderson RL, Martin OA, Djonov VG. Microbeam Radiation Therapy Controls Local Growth of Radioresistant Melanoma and Treats Out-of-Field Locoregional Metastasis. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):478-493. doi: 10.1016/j.ijrobp.2022.06.090. IF(5)=6.6 M21a
    28.    Caruso M, Emma R, Distefano A, Rust S, Poulas K, Giordano A, Volarevic V, Mesiakaris K, Boffo S, Arsenijevic A, Karanasios G, Pulvirenti R, Ilic A, Canciello A, Zuccarello P, Ferrante M, Polosa R, Li Volti G. Comparative assessment of electronic nicotine delivery systems aerosol and cigarette smoke on endothelial cell migration: The Replica Project. Drug Test Anal. 2022 Jul 25. doi: 10.1002/dta.3349. IF(5)=2.7 M22
    29.    Kovacevic Z, Lazarevic T, Maksimovic N, Grk M, Volarevic V, Gazdic Jankovic M, Djukic S, Janicijevic K, Miletic Kovacevic M, Ljujic B. Galectin 3 (LGALS3) Gene Polymorphisms Are Associated with Biochemical Parameters and Primary Disease in Patients with End-Stage Renal Disease in Serbian Population. J Clin Med. 2022 Jul 4;11(13):3874. doi: 10.3390/jcm11133874. IF(5)=4.1 M21
    30.    Milutinovic M, Cakovic A, Cocic D, Rais E, Schoch R, Simović Markovic B, Arsenijevic N, Volarevic V, Jovanović-Stevic S, Bogojeski J and Wilhelm R. Unique enantiopure camphor-based neutral arene–ruthenium(II) complexes: DNA/BSA binding, kinetic and cytotoxic studies. Journal of Coordination Chemistry, 2022; 75:11-14, 1636-1655, doi: 10.1080/00958972.2022.2106562  IF(5)=1.5 M22
    31.    Harrell CR, Pavlovic D, Miloradovic D, Stojanovic MD, Djonov V, Volarevic V*. "Derived Multiple Allogeneic Protein Paracrine Signaling (d-MAPPS)" Enhances T Cell-Driven Immune Response to Murine Mammary Carcinoma. Anal Cell Pathol (Amst). 2022 Jun 15;2022:3655595. doi: 10.1155/2022/3655595. IF(5)=3.6 M21
    32.    Živanović AS, Bukonjić AM, Jovanović-Stević S, Bogojeski J, Ćoćić D, Bijelić AP, Ratković ZR, Volarević V, Miloradović D, Tomović DL, Radić GP. Complexes of copper(II) with tetradentate S,O-ligands: Synthesis, characterization, DNA/albumin interactions, molecular docking simulations and antitumor activity. J Inorg Biochem. 2022 Aug;233:111861. doi: 10.1016/j.jinorgbio.2022.111861. IF(5)=3.6 M2133.    Harrell CR, Volarevic V, Djonov V, Volarevic A. Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases. Int J Mol Sci. 2022 Apr 19;23(9):4487. IF(5)=6.2 M21
    34.    Drweesh EA, Kuchárová V, Volarevic V, Miloradovic D, Ilic A, Radojević ID, Raković IR, Smolková R, Vilková M, Sabolová D, Elnagar MM, Potočňák I. Low-dimensional compounds containing bioactive ligands. Part XVII: Synthesis, structural, spectral and biological properties of hybrid organic-inorganic complexes based on [PdCl4]2- with derivatives of 8-hydroxyquinolinium. J Inorg Biochem. 2022 Mar;228:111697. doi: 10.1016/j.jinorgbio.2021.111697. IF(5)=3.6 M21
    35.    Caruso M, Emma R, Distefano A, Rust S, Poulas K, Zadjali F, Giordano A, Volarevic V, Mesiakaris K, Al Tobi M, Boffo S, Arsenijevic A, Zuccarello P, Giallongo C, Ferrante M, Polosa R, Li Volti G; Replica Project Group. Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project. Sci Rep. 2021 Dec 17;11(1):24182. doi: 10.1038/s41598-021-03310-y. IF(5)=5.516 M21
    36.    Harrell CR, Djonov V, Volarevic V*. The effects of cigarette smoking and nicotine on the therapeutic potential of mesenchymal stem cells. Histol Histopathol. 2022 Feb;37(2):93-100. doi: 10.14670/HH-18-400. IF(5)=1.9 M22
    37.    Harrell CR, Volarevic A, Djonov VG, Jovicic N, Volarevic V*. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Int J Mol Sci. 2021 Nov 18;22(22):12429. doi: 10.3390/ijms222212429. IF(5)=6.628 M21
    38.    Trappetti V, Fazzari JM, Fernandez-Palomo C, Scheidegger M, Volarevic V, Martin OA, Djonov VG. Microbeam Radiotherapy-A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma. Int J Mol Sci. 2021 Jul 20;22(14):7755. doi: 10.3390/ijms22147755. IF(5)=6.628 M21
    39.    Harrell CR, Volarevic V*. Apoptosis: A friend or foe in mesenchymal stem cell-based immunosuppression. Adv Protein Chem Struct Biol. 2021;126:39-62. doi: 10.1016/bs.apcsb.2021.01.002. IF(5)=4.775 M22
    40.    Harrell CR, Popovska Jovicic B, Djonov V, Volarevic V*. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases. Pathogens. 2021 Apr 1;10(4):409. doi: 10.3390/pathogens10040409. IF(5)=4.580 M21
    41.    Harrell CR, Volarevic A, Djonov V, Volarevic V*. Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders. Int J Mol Sci. 2021 Feb 1;22(3):1433. doi: 10.3390/ijms22031433. IF(5)=6.628 M21
    42.    Harrell CR, Djonov V, Volarevic V*. The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration. Int J Mol Sci. 2021 Mar 1;22(5):2472. doi: 10.3390/ijms22052472. IF(5)=6.628 M21
    43.    Harrell CR, Jovicic BP, Djonov V, Volarevic V*. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Anal Cell Pathol (Amst). 2020 Nov 20;2020:1939768.  IF(5)=2.941 M22
    44.    Miloradovic D, Miloradovic D, Markovic BS, Acovic A, Harrell CR, Djonov V, Arsenijevic N, Volarevic V*. The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration. Stem Cells Int. 2020 Jul 10;2020:8842659. IF(5)=5.305 M21
    45.    Harrell CR, Jovicic N, Djonov V, Volarevic V*. Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics. Pharmaceutics. 2020 May 22;12(5):E474. doi: 10.3390/pharmaceutics12050474. IF(5)=6.734 M21a
    46.    Harrell CR, Miloradovic D, Sadikot R, Fellabaum C, Markovic BS, Miloradovic D, Acovic A, Djonov V, Arsenijevic N, Volarevic V*. Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product "Exo-d-MAPPS" in Attenuation of Chronic Airway Inflammation. Anal Cell Pathol (Amst). 2020 Mar 20;2020:3153891. doi: 10.1155/2020/3153891. IF(5)=2.941 M22
    47.    Harrell CR, Fellabaum C, Arsenijevic A, Markovic BS, Djonov V, Volarevic V*. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma. Stem Cells Int. 2019 Dec 27;2019:7869130. doi: 10.1155/2019/7869130. IF(5)=4.135 M22
    48.    Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V*. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019 Dec 11;8(12). pii: E1605. doi: 10.3390/cells8121605. IF(5)=5.276 M21
    49.    Harrell CR, Markovic BS, Fellabaum C, Arsenijevic N, Djonov V, Volarevic V*. The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration. Biofactors. 2019 Nov 22. doi: 10.1002/biof.1587. IF(5)=4.236 M21
    50.    Volarevic V*, Simovic Markovic B, Gazdic Jankovic M, Djokovic B, Jovicic N, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N, Lukic ML. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Theranostics, 2019; 9(20): 5976-6001. doi: 10.7150/thno.33959.  IF(5)=9.108 M21a
    51.    Potez M, Fernandez-Palomo C, Bouchet A, Trappetti V, Donzelli M, Krisch M, Laissue J, Volarevic V, Djonov V. Synchrotron Microbeam Radiation Therapy as a New Approach for the Treatment of Radioresistant Melanoma: Potential Underlying Mechanisms. Int J Radiat Oncol Biol Phys. 2019; 105(5):1126-1136. doi: 10.1016/j.ijrobp.2019.08.027. IF(5)=5.652 M21a
    52.    Volarevic V*, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells. 2019 Jul 12;8(7). pii: E709. doi: 10.3390/cells8070709. IF(5)=5.276 M21
    53.    Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V*. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019;8. doi: 10.3390/cells8050467. IF(5)=5.276 M21
    54.    Dimova I, Karthik S, Makanya A, Hlushchuk R, Semela D, Volarevic V, Djonov V.  SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception. J Cell Mol Med. 2019;23:3916-3926. doi: 10.1111/jcmm.14269. IF(5)=4.428 M21
    55.    Volarevic V*, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci. 2019 Mar 13;26(1):25. IF(5)=4.724 M21
    56.    Harrell CR, Gazdic M, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V*. Therapeutic potential of amniotic fluid derived mesenchymal stem cells based on their differentiation capacity and immunomodulatory properties. Curr Stem Cell Res Ther. 2019 Feb 22. doi: 10.2174/1574888X14666190222201749. IF(5)=2.286 M23
    57.    Harrell CR, Markovic BS, Fellabaum C, Arsenijevic A, Volarevic V*. Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother. 2019 Jan;109:2318-2326. IF(5)=4.392 M21
    58.    Jakovljevic J, Harrell CR, Fellabaum C, Arsenijevic A, Jovicic N, Volarevic V*. Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. Biomed Pharmacother. 2018 Aug;104:404-410. IF(5)=3.615 M21
    59.    Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Arsenijevic N, Volarevic V*. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. Adv Exp Med Biol. 2018;1089:47-57.  IF(5)=2.148 M22
    60.    Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M. Stem Cells Therapy for Spinal Cord Injury. Int J Mol Sci. 2018 Mar 30;19(4). IF(5)=4.331 M21
    61.    Gazdic M, Simovic Markovic B, Arsenijevic A, Jovicic N, Acovic A, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N, Lukic ML, Volarevic V*. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018 May;24(5):687-702. IF(5)=4.254 M21
    62.    Harrell CR, Djonov V, Fellabaum C, Volarevic V*. Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin. Int J Med Sci. 2018;15(3):274-279.  IF(5)=2.636 M21
    63.    Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Volarevic V*. Molecular mechanisms underlying therapeutic potential of pericytes. J Biomed Sci. 2018;25(1):21. doi: 10.1186/s12929-018-0423-7. IF(5)=4.091 M21
    64.    Nikolic A, Simovic Markovic B, Gazdic M, Harrell CR, Fellabaum C, Djonov V, Jovicic N, Arsenijevic N, Lukic ML, Stojkovic M, Volarevic V*. Intraperitoneal administration of mesenchymal stem cells ameliorate acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Biomed Pharmacother. 2018;100:426-432. IF(5)=3.615 M21
    65.    Milosavljevic N, Gazdic M, Simovic Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z, Jovicic N, Jeftic I, Djonov V, Arsenijevic N, Lukic ML, Volarevic V*. Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells – an experimental study. Transpl Int. 2018;31:102-115. IF(5)=3.145 M21
    66.    Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M. Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 2018;15:36-45. IF(5)=2.636 M21
    67.    Markovic BS, Kanjevac T, Harrell CR, Gazdic M, Fellabaum C, Arsenijevic N, Volarevic V. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. Stem Cell Rev Rep. 2018 Apr;14(2):153-165. IF(5)=4.073 M21
    68.    Acovic A, Gazdic M, Jovicic N, Harrell CR, Fellabaum C, Arsenijevic N, Volarevic V*. Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract. Therap Adv Gastroenterol. 2018 Dec 6;11:1756284818815334. doi: 10.1177/1756284818815334. 
    69.    Acovic A, Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Gajovic N, Jovanovic M, Zdravkovic N, Kanjevac T, Harrell CR, Fellabaum C, Dolicanin Z, Djonov V, Arsenijevic N, Lukic ML, Volarevic V*. Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis. Therap Adv Gastroenterol. 2018 Aug 24;11:1756284818793558. doi: 10.1177/1756284818793558. 
    70.    Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V, Arsenijevic N. Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential. Biofactors. 2017;43:633-644. IF(5)=4.155 M21
    71.    Milosavljevic N, Gazdic M, Simovic Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z, Djonov V, Lukic ML, Volarevic V*. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23:1040-1050. IF(5)=4.005 M21
    72.    Arsenijevic A, Harrell CR, Fellabaum C, Volarevic V*. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Anal Cell Pathol (Amst). 2017;2017:7492836. IF(5)=1.184 M23
    73.    Volarevic V, Lako M, Erceg S, Stojkovic M. Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases. Stem Cells Int. 2017;2017:7379136. IF(5)=3.983 M22
    74.    Gazdic M, Simovic Markovic B, Jovicic N, Misirkic-Marjanovic M, Djonov V, Jakovljevic V, Arsenijevic N, Lukic ML, Volarevic V*. Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response. Stem Cells Int 2017;2017:6294717. IF(5)=3.983 M22
    75.    Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Jeremic J, Djonov V, Arsenijevic N, Lukic ML, Volarevic V*. Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner. Stem Cells Int. 2017;2017:1315378. IF(5)=3.983 M22
    76.    Gazdic M, Arsenijevic A, Markovic BS, Volarevic A, Dimova I, Djonov V, Arsenijevic N, Stojkovic M, Volarevic V*. Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases. Int J Biol Sci. 2017; 13:1109-1117. IF(5)=4.950 M21
    77.    Gazdic M, Simovic Markovic B, Vucicevic L, Nikolic T, Djonov V, Arsenijevic N, Trajkovic V, Lukic ML, Volarevic V*. Mesenchymal stem cells protect from acute  liver injury by attenuating hepatotoxicity of liver NKT cells in iNOS and IDO dependent manner. J Tissue Eng Regen Med. 2018 Feb;12(2):e1173-e1185. doi: 10.1002/term.2452. IF(5)=3.435 M21
    78.    Arsenijevic M, Milovanovic M, Jovanovic S, Arsenijevic N, Markovic BS, Gazdic M, Volarevic V*. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells. J Biol Inorg Chem. 2017 2017; 22:807-817. IF(5)=2.745 M21
    79.    Simovic Markovic B, Jovanovic I, Volarevic V, Zdravkovic N, Jovanovic M, Zdravkovic N, Maric V, Arsenijevic N, Lukic ML. Potential inversely immunomodulatory roles of Galectin-1 and Galectin-3 in ulcerative colitis. Wulfenia. 2016; 23:188-205. IF(5)=1.429 M22
    80.    Gazdic M, Volarevic V, Arsenijevic A, Erceg S, Moreno-Manzano V, Arsenijevic N, Stojkovic M. Stem Cells and Labeling for Spinal Cord Injury. Int J Mol Sci. 2016 Dec 26;18(1). pii: E6. doi: 10.3390/ijms18010006. IF(5)=3.482 M21
    81.    Potočňák I, Vranec P, Farkasová V, Sabolová D, Vataščinová M, Kudláčová J, Radojević ID, Čomić LR, Markovic BS, Volarevic V, Arsenijevic N, Trifunović SR. Low-dimensional compounds containing bioactive ligands. Part VI: Synthesis, structures, in vitro DNA binding, antimicrobial and anticancer properties of first row transition metal complexes with 5-chloro-quinolin-8-ol. J Inorg Biochem 2016; 154:67-77. IF(5)=3.207 M21
    82.    Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, Mitrovic S, Milosavljevic M, Besra G, Trajkovic V, Arsenijevic N, Lukic ML, Volarevic V*. Gal-3 plays an important pro-inflammatory role in the induction phase of acute colitis by promoting activation of NLRP3 inflammasome and production of IL-β in macrophages. J Crohns Colitis 2016;10(5):593-606. IF(5)=5.926 M21
    83.    Simovic Markovic B, Nikolic, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V*. Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem cell International 2016; 2016: 2640746. IF(5)=3.390 M22
    84.    Nurkovic JS, Volarevic V*, Lako M, Armstrong L, Arsenijevic N, Stojkovic M. Aging of stem and progenitor cells: mechanisms, impact on the therapeutic potential and rejuvenation. Rejuvenation Res 2016;19(1):3-12. IF(5)=2.689 M22
    85.    Nikolic A, Volarevic V, Armstrong L, Lako M, Stojkovic M. Primordial Germ Cells: Current Knowledge and Perspectives. Stem Cells International 2016; 2016:1741072. IF(5)=3.390 M22
    86.    Gazdic M, Volarevic V, Arsenijevic N, Stojkovic M. Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases. Stem Cell Rev 2015;11(2):280- 7. IF(5)=3.595 M21
    87.    Mijajlovic MZ, Nikolic MV, Jevtic VV, Ratkovic ZR, Simovic Markovic B, Volarevic V, Arsenijevic NN, Novakovic SB, Bogdanovic GA, Trifunovic SR, Radic GR. Cytotoxicity of palladium (II) complexes with some alkyl derivates of thiosalicylic acid. Crystal structure of the bis (S-butylthiosalicylate) palladium (II) complex, [Pd(S-bu-thiosal)2]. Polyhedron 2015; 90:34–40. IF(5)=1.973 M22
    88.    Volarevic V, Misirkic M, Vucicevic L, Paunovic V, Simovic Markovic B, Stojanovic M, Milovanovic M, Jakovljevic V, Micic D, Arsenijevic N, Trajkovic V, Lukic ML. Metformin aggravates immune-mediated liver injury in mice. Arch Toxicol 2015; 89(3):437-450. IF(5)=5.574 M21a
    89.    Volarevic V, Markovic BS, Bojic S, Stojanovic M, Nilsson U, Leffler H, Besra GS, Arsenijevic N, Paunovic V, Trajkovic V, Lukic ML. Gal-3 regulates the capacity of dendritic cells to promote NKT cell-induced liver injury. Eur J Immunol 2015; 45(2):531-543. IF(5)=4.315 M21
    90.    Volarevic V, Paunovic V, Markovic Z, Simovic Markovic B, Misirkic-Marjanovic M, Todorović Marković B, Bojic S, Vucicevic L, Jovanovic S, Arsenijevic N, Holclajtner-Antunović I, Milosavljevic M, Dramicanin M, Kravic-Stevovic T, Ciric D, Lukic ML, Trajkovic V. Large Graphene Quantum Dots Alleviate Immune-Mediated Liver Damage. ACS Nano 2014; 8(12):12098-12109. IF(5)=14.412 M21a+
    91.    Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 2014; 32(11):2818-2823. IF(5)=7.532 M21a
    92.    Volarevic V, Bojic S, Nurkovic J, Volarevic A, Ljujic B, Arsenijevic N, Lako M, Stojkovic M. Stem Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges. BioMed Research International 2014; 2014:507234. IF(5)=1.593 M22
    93.    Bojic S, Volarevic V, Ljujic B, Stojkovic M. Dental stem cells-characteristics and potential. Histol Histopathol 2014; 29(6):699-706. IF(5)=2.145 M22
    94.    Vukcevic G, Volarevic V, Raicevic S, Tanaskovic I, Milicic B, Vulovic T, Arsenijevic S. A novel semi-quantitative method for measuring tissue bleeding. Histol Histopathol 2014; 29(3):353-360. IF(5)=2.145 M22
    95.    Ljujic B, Milovanovic M, Volarevic V, Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML, Stojkovic M. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep 2013; 3:2298. doi: 10.1038/srep02298. IF(5)=5.078 M21a
    96.    Dimitrijević DP, Glođović VV, Radić GP, García-Granda S, Menéndez-Taboada L,  Milovanović M, Volarević V, Arsenijević N, Bogdanović GA, Trifunović SR. Stereospecific ligands and their complexes. Part XV. Synthesis, characterization and cytotoxicity of novel platinum (IV) complexes with some esters of ethylenediamine-N,N0-di-S,S-(2,20-dibenzyl)acetic acid. Crystal structure of O,O0-dipropyl-ethylenediamine-N,N0-di-S, S-(2,20-dibenzyl)acetate dihydrochloride. Inorganica Chimica Acta 2013; 402:83–89.  IF(5)=1.991 M22
    97.    Volarevic V, Vujic JM, Milovanovic M, Kanjevac T, Volarevic A, Trifunovic SR, Arsenijevic N. Cytotoxic effects of palladium(II) and platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N’-di-2-(4-methyl) pentanoic acid on human colon cancer cell lines. J BUON 2013; 18(1):131- 137. IF(5)=0.673 M23
    98.    Volarevic V, Erceg S, Bhattacharya SS, Stojkovic P, Horner P, Stojkovic M. Stem cell based therapy for spinal cord injury. Cell Transplant 2013; 22(8):1309- 1323. IF(5)=3.420 M21
    99.    Arsenijevic S, Vukcevic-Globarevic G, Volarevic V*, Macuzic I, Todorovic P, Tanaskovic I, Mijailovic M, Raicevic S, Jeremic B. Continuous controllable balloon dilation: a novel approach for cervix dilation. Trials 2012; 13(1):196. IF(5)=2.612 M22
    100.    Volarevic A, Ljujic B, Volarevic V, Milovanovic M, Kanjevac T, Lukic A, Arsenijevic N. A new semiquantitative method for evaluation of metastasis progression. J BUON 2012; 17:585-590. IF(5)=0.653 M23
    101.    Milovanovic M, Volarevic V, Ljujic B, Radosavljevic G, Jovanovic I, Arsenijevic N, Lukic ML. Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Miceby Enhancing Polarization of APC to Inflammatory Phenotype. Plos ONE 2012;7(9):e45225. IF(5)=4.244 M21a
    102.    M. Arsenijević, M. Milovanović, V. Volarević, D. Čanović, N. Arsenijević, T. Soldatović, S. Jovanović, Ž.D. Bugarčić. Cytotoxic properties of platinum(IV) and dinuclear platinum(II) complexes and their ligand substitution reactions with guanosine-50-monophosphate. Transition Met Chem 2012; 37(5):481-488. IF(5)=1.073 M22
    103.    J.M. Vujić, G.N. Kaluđerović, B.B. Zmejkovski, M. Milovanović, V. Volarević, N. Arsenijević, T.P. Stanojković, S.R. Trifunović. Stereospecific ligands and their complexes. Part X: Synthesis, characterization and in vitro antitumoral activity of platinum(IV) complexes with O,O0-dialkyl-(S,S)-ethylenediamine-N,N0- di-2-(4-methyl)pentanoate ligands. Inorganica Chimica Acta 2012; 390:123–128. IF(5)=1.833 M22
    104.    G. Radosavljevic, V. Volarevic, I. Jovanovic, M. Milovanovic, N. Pejnovic, N. Arsenijevic, D.K. Hsu, M.L. Lukic. The roles of Galectin-3 in autoimmunity and tumor progression. Immunol Res 2012; 52(1-2):100-110. IF(5)=2.694 M22
    105.    M. Milovanovic, V. Volarevic, G. Radosavljevic, I. Jovanovic, N. Pejnovic, N. Arsenijevic, M. L. Lukic. IL-33/ST2 axis in inflammation and immunopathology. Immunol Res 2012; 52(1-2):89-99. IF(5)=2.694 M22
    106.    Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 2012; 55(6):1954-1964. IF(5)=11.400 M21a+
    107.    T. Kanjevac, M. Milovanovic, V. Volarevic, ML. Lukic, N. Arsenijevic, D. Markovic, N. Zdravkovic, Z. Tesic, A. Lukic. Cytotoxic effects of glass ionomer cements on human dental pulp stem cells correlate with fluoride release. Med Chem 2012; 8(1): 40-45(6). IF(5)=1.362 M23
    108.    M. Arsenijević, M. Milovanović, V. Volarević, A. Djeković, T. Kanjevac, N. Arsenijević, S. Đukić and ŽD. Bugarčić. Cytotoxicity of gold (III) complexes on A549 human lung carcinoma epithelial cell line. Med Chem 2012; 8(1):2-8(7). IF(5)=1.362 M23
    109.    Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N. and Lukic M. Protective role of IL-33/ST2 axis in Con Ainduced hepatitis. Journal of Hepatology 2012; 56(1):26-33. IF(5)=8.897 M21a
    110.    Volarevic V, Ljujic B, Lukic A, Arsenijevic N, Stojkovic M. Human Stem Cell Research and Regenerative Medicine - Present and Future. British Medical Bulletin 2011; 99:155-168. IF(5)=4.353 M21 
    111.    Vujić JM, Kaluđerović GN, Milovanović M, Zmejkovski BB, Volarević V, Zivić D, Durđević P, Arsenijević N, Trifunović SR. Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamineN,N'-di-2-(4-methyl)pentanoic acid. Eur J Med Chem 2011; 46(9):4559-4565. IF(5)=3.509 M21
    112.    Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M. Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 2011; 29:5-10. IF(5)=8.612 M21a+
    113.    Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 2010; 43:255-263. IF(5)=2.352 M22
    114.    Vujić JM, Cvijović M, Kaluderović GN, Milovanović M, Zmejkovski BB, Volarević V, Arsenijević N, Sabo TJ, Trifunović SR. Palladium(II) complexes with R2edda derived ligands. Part IV. O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic leukemia (CLL) cells. Eur J Med Chem 2010; 45(9):3601- 3606. IF(5)=3.356 M21
    115.    Milovanović M, Djeković A, Volarević V, Petrović B, Arsenijević N, Bugarcić ZD. Ligand substitution reactions and cytotoxic properties of [Au(L)Cl2](+) and [AuCl2(DMSO)2]+ complexes (L=ethylenediamine and S-methyl-l-cysteine). J Inorg Biochem 2010;104(9):944-949. IF(5)=3.386 M21
    116.    Volarevic V, Milovanovic M, Djekovic A, Petrovic B, Arsenijevic N, Bugarcic ZD. The cytotoxic effects of some selected gold(III) complexes on 4T1 cells and their role in the prevention of breast tumor growth in BALB/c mice. J BUON. 2010 Oct-Dec;15(4):768-73.
  • Radovi u ostalim časopisima:

    1. Volarevic V, Kastratovc N, Volarevic A. The effects of prolonged exposure to cigarette smoke on phenotype and function of innate immune cellsin the lungs. Acta Medica Medianae 2025, doi: 10.5633/amm.2025.0418.  M52
    2. Harrell CR, Fellabaum C, Simovic Markovic B, Miloradovic D, Acovic A, Miloradovic D, Arsenijevic N, and Volarevic V*. Exo-d-MAPPS attenuates production of inflammatory cytokines and promotes production of inflammatory cytokines in peripheral blood mononuclear cells. Ser J Exp Clin Res 2022; 23(1): 75-82.  M51
    3. Miloradovic D, Miloradovic D, Gazdic Jankovic M , Simovic Markovic B , Harrell CR, Fellabaum C, Arsenijevic N , Lukic A and Volarevic V*. Mesenchymal stem cells attenuate acute liver failure by promoting expansion of regulatory T cells in indoleamine 2,3-dioxigenase dependent manner. Ser J Exp Clin Res. 2020; 21(3): 257-262. M51
    4. Harrell CR, Fellabaum C, Simovic Markovic B, Arsenijevic A, Volarevic V*. Therapeutic Potential of “Exosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes D-Mapps” is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors. Ser J Exp Clin Res. 2019; 20(3): 189-197. M51
    5. Djokovic B, Gazdic M, Harrell CR, Fellbaum C, Volarevic V*. New insights in the pathogenesis of cisplatin-induced nephrotoxicity. Ser J Exp Clin Res. 2019; doi:10.2478/sjecr-2019-0012.  M51
    6. Simovic Markovic B, Milosavljevic N, Arsenijevic A, Gazdic M, Lukic ML and Volarevic V*. Bacterial flora play important roles in acute dextran sulphate sodium-induced colitis but arenot involved in Gal-3 dependent modulation of colon inflammation. Ser J Exp Clin Res 2017; 18 (3):213-220. M51
    7. Gazdic M, Volarevic V and Stojkovic M. Stem cells: new hope for spinal cord injury. Ser J Exp Clin Res 2015; 16 (1): 3-8. M51
    8. Simovic Markovic B, Vucicevic Lj, Bojic S, Volarevic V. The role of autophagy in immunity and autoimmune diseases. Ser J Exp Clin Res 2014; 15 (4): 223-229. M52
    9. Volarevic V, Milovanovic M, Djekovic A, Bugarcic Z and Arsenijevic N. Cytotoxic effects of selected gold (III) complexes on the murine BCl-1 B lineage leukaemia cell line. Ser J Exp Clin Res 2012; 13 (3): 99-102.  M52
    10. Pantic J, Volarevic V, Djukic A. Experimental models of diabetes mellitus. Ser J Exp Clin Res 2011; 12: 29-35.  M52
    11. Kanjevac T, Milovanovic M, Volarevic V, Arsenijevic N. Fluoride release from glass ionomer cements correlates with necrotic death of human dental pulp stem cells.  Ser J Exp Clin Res 2011; 12: 67-70.  M52
    12. Volarevic V, Milovanovic M, Arsenijevic N, Lukic ML. A new semi-quantitative method for determininig liver damage after Concanavalin A administration. Ser J Exp Clin Res 2010; 11: 45-48.  M52
  • Radovi na naučnim skupovima međunarodnog značaja:

    1. Volarevic V. Mesenchymal stem cell-based therapy: importance of communication with T regulatory cells”. The second Cellfit workshop-Cells communicate, Belgrade, March 2019.Book of abstracts (ISBN 978-86-80335-08-7) pages 13-14. 
    2. Arsenijevic A, Simovic Markovic B, Gazdic Jankovic M, Lukic ML and Volarevic V. T regulatory cell-dependent attenuation of neutrophils is crucially important for the attenuation of cisplatin-induced acute renal failure. The second Cellfit workshop-Cells communicate, Belgrade, March 2019.Book of abstracts (ISBN 978-86-80335-08-7) pages 47-48. 
    3. Djokovic B, Simovic Markovic B, Gazdic Jankovic M, Arsenijevic N, Lukic ML and Volarevic V. Gal-3 promotes TLR-2-dependent activation of IDO1/KYN pathway in renal DCs resulting in increased expansion of immunosuppressive Tregs. The second Cellfit workshop-Cells communicate, Belgrade, March 2019.Book of abstracts (ISBN 978-86-80335-08-7) pages 59-60. 
    4. Gazdic M, Simovic Markovic B, Misirkic M, Arsenijevic N, Lukic ML, Trajkovic V, Volarevic V. Gentic inhibition of Atg5 in mesenchymal stem cells abrogates their capacity to suppress NKT cells in acute liver injury. The second Cellfit workshop-Cells communicate, Belgrade, March 2019.Book of abstracts (ISBN 978-86-80335-08-7) pages 63-64. 
    5. Simovic Markovic B, Gazdic Jankovic M, Acovic A, Arsenijevic N, Lukic ML and Volarevic V. Gal-3 regulates Kynurenine-dependent cross-talk between dendritic cells and T regulatory cells in ulcerative colitis. The second Cellfit workshop-Cells communicate, Belgrade, March 2019.Book of abstracts (ISBN 978-86-80335-08-7) pages 91-92. 
    6. Simovic Markovic B, Acovic A, Gazdic M, Arsenijevic A, Volarevic A, Kanjevac T, Jovicic N, Jakovljevic J, Arsenijevic M, Arsenijevic N, Lukic ML and Volarevic V. Strain dependent difference in the progression of dextran sulphate sodium induced colitis is a consequence of the cross-talk between colon-infiltrating dendritic cells and T regulatory cells. 13th Congress of ECCO-European Crohn’s and Colitis Organization, Vienna, Austria, 2018, February 14-17. Abstract book. Journal of Crohns & Colitis, 2018; Supp 1: S141. 
    7. Acovic A, Simovic MarkovicB, Gazdic M, Arsenijevic A, Volarevic A, Kanjevac T, Jovicic N, Jakovljevic J, Arsenijevic M, Arsenijevic N, Lukic ML and Volarevic V. Intraperitoneal injection of bone marrow derived-mesenchymal stem cells increases total number of colon-infiltrating inflammatory dendritic cells and macrophages and aggravates colitis in BALBc mice. 13th Congress of ECCO-European Crohn’s and Colitis Organization, Vienna, Austria, 2018, February 14-17. Abstract book. Journal of Crohns & Colitis, 2018; Supp 1: S127. 
    8. Volarevic V, Gazdic M, Simovic Markovic B, Arsenijevic A, MIlosavljevic N, Acovic A, Jakovljevic V, Djonov V, Trajkovic V, Arsenijevic N, Lukic ML. Modulation of immune response in acute liver failure. 4th Congress of Physiological Sciences of Serbia with international participation “Current trends in physiological sciences: from cell signals to the biology of aging”, Nis, September 2018. Abstract book (ISBN 978-86-900597-0-6) page 75. 
    9. Simovic Markovic B, Djokovic B, Gazdic M, Miloradovic D, Acovic A, Arsenijevic A, Miloradovic D, Arsenijevic N, Lukic ML, Volarevic V. Gal-3 promotes expression of indoleamine 2,3-dioxygenase in renal DCs resulting with attenuation of acute kidney injury. 4th Congress of Physiological Sciences of Serbia with international participation “Current trends in physiological sciences: from cell signals to the biology of aging”, Nis, September 2018. Abstract book (ISBN 978-86-900597-0-6) page 99. 
    10. Miloradovic D, Gazdic M, Simovic Markovic B, Arsenijevic A, Acovic A, Miloradovic D, Arsenijevic N, Djonov V, Volarevic V. The effect of mesenchymal stem cells on agiogenesis and liver inflammation after partial hepatectomy. 4th Congress of Physiological Sciences of Serbia with international participation “Current trends in physiological sciences: from cell signals to the biology of aging”, Nis, September 2018. Abstract book (ISBN 978-86-900597-0-6) page 104. 
    11. Gazdic M, Simovic Markovic B, Vucicevic Lj, Paunovic V, Arsenijevic A, Acovic A, Misirkic M, Arsenijevic N, Lukic ML, Trajkovic V, Volarevic V. Activation of autophagy is important for mesenchymal stem cell-based attenuation of acute hepatitis. 4th Congress of Physiological Sciences of Serbia with international participation “Current trends in physiological sciences: from cell signals to the biology of aging”, Nis, September 2018. Abstract book (ISBN 978-86-900597-0-6) page 111. 
    12.  Arsenijevic A, Simovic Markovic B, Gazdic M, Miloradovic D, Acovic A, Miloradovic D, Arsenijevic N, Lukic ML, Volarevic V. Gal-3 deletion activates colon infiltrating DCs to produce inflammatory cytokines and generate detrimental Th1 and Th17 immune response in chronic dextran sodium sulphate induced colitis in mice. 4th Congress of Physiological Sciences of Serbia with international participation “Current trends in physiological sciences: from cell signals to the biology of aging”, Nis, September 2018. Abstract book (ISBN 978-86-900597-0-6) page 113. 
    13. Simovic Markovic B, Gazdic M, Arsenijevic A, Volarevic A, Djonov V, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver NKT cells in IDO dependent manner. 8th Molecular Immunology & Immunogenetics Congress, Rome, Italy, 2017, March 20-21. J Immunome Res 2017, 13:1 (Suppl). 
    14. Gazdic M, Simovic Markovic B, Arsenijevic A, Volarevic A, Milosavljevic N, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between il-17 producing and regulatory nkt cells. 4th Conference of translational medicine on pathogenesis and therapy of immune-mediated diseases, Palermo, Italy, 2017, March 27-29. Book of Abstracts, pages 58-59. 
    15. Simovic Markovic B, Gazdic M, Arsenijevic A, Volarevic A, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Intraperitoneal injection of mesenchymal stem cells increases infiltration of inflammatory dendritic cells in the colon and aggravates dextran sodium sulphate-induced colitis in th2-dominant mouse strain. 4th Conference of translational medicine on pathogenesis and therapy of immune-mediated diseases, Palermo, Italy, 2017, March 27-29. Book of Abstracts, pages 71-72. 
    16. Potočňák I, Drweesh SA, Farkasová V, Lüköová A, Arsenijevic A, Djordjevic D, Volarevic V. Structures and in vitro cytotoxic properties of Pd(II) complexes with 7-bromo-quinolin-8-ol. XXVI International Conference on Coordination and Bioinorganic Chemistry, June 4-9, 2017, Smolenice, Slovakia. Book of Abstracts, page 87. 
    17. Gazdic M, Milosavljevic N, Simovic Markovic, Arsenijevic A, Acovic A, Volarevic A, Delic J, Stojic I, Kanjevac T, Jakovljevic V, Arsenijevic N, Lukic ML and Volarevic V. Mesenchymal stem cells reduce infiltration of Il-17 producing nkt cells in the liver and attenuate acute liver failure in paracrine manner. Joint meeting of national physiological Hungarian and Serbian physiological societies: New perspectives in physiological research-young investigator forum, May 25-27, 2017, Subotica, Serbia. Book of Abstracts (ISBN 978-86-904799-9-3), page 56. 
    18. Simovic Markovic B, Gazdic M, Arsenijevic A, Jeremic J, Volarevic A, Acovic A, Delic J, Kanjevac T, Jakovljevic V, Arsenijevic N, Lukic ML and Volarevic V. Mesenchymal stem cells attenuate cisplatin-induced nephrotoxicity in iNOS dependent manner. Joint meeting of national physiological Hungarian and Serbian physiological societies: New perspectives in physiological research-young investigator forum, May 25-27, 2017, Subotica, Serbia. Book of Abstracts (ISBN 978-86-904799-9-3), page 57. 
    19. Acovic A, Simovic Markovic B, Gazdic M, Arsenijevic A, Volarevic A, Delic J, Kanjevac T, Arsenijevic N, Lukic ML, and Volarevic V. Mesenchymal stem cells attenuate experimental colitis in C57BL/6 mice by suppressing infiltration of antigen presenting cells in the colon. Joint meeting of national physiological Hungarian and Serbian physiological societies: New perspectives in physiological research-young investigator forum, May 25-27, 2017, Subotica, Serbia. Book of Abstracts (ISBN 978-86-904799-9-3), P20 page 86. 
    20. Delic J, Simovic Markovic B, Gazdic M, Arsenijevic A, Volarevic A, Acovic A, Nikolic T, Kanjevac T, Jakovljevic V, Arsenijevic N, Lukic ML, and Volarevic V. MSCs promote expansion of IL-10 producing CD4+ T cells and attenuate carbon tetrachloride-induced liver fibrosis in mice. Joint meeting of national physiological Hungarian and Serbian physiological societies: New perspectives in physiological research-young investigator forum, May 25-27, 2017, Subotica, Serbia. Book of Abstracts (ISBN 978-86-904799-9-3), P21 page 87. 
    21. Arsenijevic A, Simovic Markovic B, Gazdic M, Volarevic A, Acovic A, Delic J, Jakovljevic V, Kanjevac T, Arsenijevic N, Lukic ML and Volarevic V. Mesenchymal stem cells promote metastasis of lung cancer cells by suppressing anti-tumor immune response. Joint meeting of national physiological Hungarian and Serbian physiological societies: New perspectives in physiological research-young investigator forum, May 25-27, 2017, Subotica, Serbia. Book of Abstracts (ISBN 978-86-904799-9-3), P22 page 88. 
    22. Volarevic V, Nikolic A, Simovic Markovic B, Gazdic M, Djordjevic I, Dasic M, Arsenijevic N, Lukic ML. Mesenchymal stem cells protect from acute dextran sulphate sodium-induced colitis by attenuating function of antigen presenting cells. 10th Congress of ECCO-European Crohn’s and Colitis Organization, Barcelona, Spain, 2015. Abstract book. Journal of Crohns & Colitis, 2015 Supplement; 9: S97-S98. 
    23. Volarevic V, Gazdic M, Simovic Markovic B, Nikolic A, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic M. Mesenchymal stem cells attenuate acute liver injury mediated by NKT cells. 3rd Belgrade EFIS symposium on immunoregulation; Immunity, Infection, Autoimmunity and Aging, Arandjelovac, Serbia, 2015, Book of Abstracts, page 45. 
    24. Simovic Markovic B, Gazdic M, Nikolic A, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic M, Volarevic V. Genetic deletion of Galectin-3 attenuate dextran sodium sulphate colitis in mice. 3rd Belgrade EFIS symposium on immunoregulation; Immunity, Infection, Autoimmunity and Aging, Arandjelovac, Serbia, 2015, Book of Abstracts, page 44. 
    25. Volarevic V, Simovic Markovic B, Bojic S, Nikolic A, Gazdic M, Jakovljevic V, Arsenijevic N, Lukic ML. Immunomodulation of acute liver injury. 3rd Congress of Physiological Sciences of Serbia with International participation, Belgrade, Serbia, 2014, Book of Abstracts, page 40. 
    26. Volarevic V, Milovanovic M, Simovic Markovic B, Bojic S, Stojanovic M, Arsenijevic N, Lukic ML. The Pro-inflammatory role of Galectin-3 in acute liver injure. The International Liver Congress, 48th annual meeting of the European Association for the Study of the Liver, Netherlands, Amsterdam 2013. Abstract Book. Journal of Hepatology 2013 Supplement No1, vol. 58, S150. 
    27. Volarevic V, Milovanovic M, Simovic Markovic B, Bojic S, Stojanovic M, Arsenijevic N, Besra G, Lukic ML. Galectin 3 affects DC:NKT cell interactions in the development of αGalCer-induced hepatitis. 15th International Congress of Immunology, Milan, Italy, August 22-27, 2013. Book of Abstracts, page 62. 
    28. Volarević V, Milovanović M, Djeković A, Petrović B, Arsenijević N, Bugarčić ZD. In vitro and in vivo antitumor activity of selected gold (III) complexes on 4T1 mouse breast cancer cell line.Preclinical testing of active substances and cancer research with international symposium on anti-cancer agents, cardiotoxicity and neurotoxicity.  March 16-19, 2011, Kragujevac, Serbia. Abstract book page 11. 
    29. Baskić D, Popović S, Zelen I, Djurdjević P, Milovanović M, Volarević V, Arsenijević N. Natural product Korbazol exerts cytotoxicity against human colon carcinoma cell lines. Preclinical testing of active substances and cancer research with international symposium on anti-cancer agents, cardiotoxicity and neurotoxicity.  March 16-19, 2011, Kragujevac, Serbia. Abstract book page 36. 
    30. Vujić J, Milovanović M, Volarević V, Arsenijević N, Trifunović S. Antitumoral activity of Platinum (IV) complex with O,O’-diethyl ester of (S,S)-ethylenediamine-N,N’--di-2-(4-methyl)-pentanoic acis dihydrochloride. Preclinical testing of active substances and cancer research with international symposium on anti-cancer agents, cardiotoxicity and neurotoxicity.  March 16-19, 2011, Kragujevac, Serbia. Abstract book page 54. 
    31. Milovanović M, Volarević V, Vujić JM, Trifunović SR, Arsenijević N. In vitro antitumoral activity of Platinum (II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine -N,N’-di-2-(4- methyl) pentanoic acid on CLL cells. Preclinical testing of active substances and cancer research with international symposium on anti-cancer agents, cardiotoxicity and neurotoxicity.  March 16-19, 2011, Kragujevac, Serbia. Abstract book page 55. 
    32. Kanjevac T, Milovanović M, Volarević V, Arsenijević N. Cytotoxic effects of glass ionomer cements on human pulp derived mesenchymal stem cells.Preclinical testing of active substances and cancer research with international symposium on anti-cancer agents, cardiotoxicity and neurotoxicity.  March 16-19, 2011, Kragujevac, Serbia. Abstract book page 74.


    33. Kastratovic N, Markovic V, Arsenijevic A, Volarevic A, Dimitrijevic Stojanovic M, Jakovljevic V, Volarevic V. Combustible cigarettes and electronic nicotine delivery devices modulate phenotype and function of murine lung-infiltrated immune cells, affecting progression of chronic lung inflammation. 6th Summit Tobacco Harm Reductions, 25-26 September 2023 Athens, Greece. Abstract book page 47. M34


    34. Markovic V, Pavlovic D, Papic D, Kastratovic N,  Dimitrijevic Stojanovic M, Arsenijevic A, Volarevic A, Jakovljevic V, Volarevic V. Exposition to cigarette smoke considerably reduces capacity of MSC to suppress immune cell-driven hepatitis. 6th Summit Tobacco Harm Reductions, 25-26 September 2023 Athens, Greece. Abstract book page 49. M34


    35. Konstantinos Partsinevelos, Rosalia Emma, Virginia Fuochi, Alfio Distefano, Sonja Rust, Fahad Zadjali, Mohammed  Al-Tobi, Antonio Giordano, Ang Sun, Vladislav Volarevic, Konstantinos Poulas, Pio-Maria Furneri1, Riccardo Polosa, Giovanni Li-Volti, Massimo Caruso and the Replica Project Group. Genotoxicity induced by cigarette smoke and modified risk products (MRPs). 6th Summit Tobacco Harm Reductions, 25-26 September 2023 Athens, Greece. Abstract book page 71. M34


    36. Kastratovic N, Arsenijevic A, Milosevic Djordjevic , Volarevic A, Spasic B, Volarevic V. Efects of tobacco heated products onviablity, proliferation and cytokine production of mesenchymal stem cells isolated from periodontal ligament. 58th Congress of European Scientists of Toxicology, 8-11 September 2024, Copenhagen, Denmark Toxicology Letters 39982, page S334.
  • Radovi na domaćim naučnim skupovima:

    1. Владислав Воларевић. Терапијски потенцијал мезенхимских матичних ћелија у лечењу инфламацијских болести јетре. Први спрпски конгрес молекулске медицине, Фоча, 2022. Књига сажетака 31. М64


    2. Александар Ацовић, Владислав Воларевић, Бојана Симовић Марковић, Татјана Кањевац, Милица Величковић, Миа Ракић, Ана Игић, Владимир Ристић. Лингва пликата: нови потенцијалн знак улцерознг колитиса. Први спрпски конгрес молекулске медицине, Фоча, 2022. Књига сажетака 12. М64


    3.  Драгана Милорадовић, Драгица Павловић, Небојша Арсенијевић, Владислав Воларевић. Зависност модулације антитуморског имунског одговора од времена примене мезенхимских матичних ћелја у мишјем карциному дојке. Први спрпски конгрес молекулске медицине, Фоча, 2022. Књига сажетака 47. М64


    4. Драгица Павловић, Драгана Милорадовић, Александар Арсенијевић, Александар Илић, Владислав Воларевић. Утицај дуванског дима на хепатопротективна својства мезенхимских матичнх ћелија. Први спрпски конгрес молекулске медицине, Фоча, 2022. Књига сажетака 50. М64


    5. Volarevic A, Simovic Markovic B, Volarevic V. Scientific partnership between researchers from the Faculty of Medical Sciences University of Kragujevac and Swiss scientists within SCOPES. XXIII skup TRENDOVI razvoja, Zlatibor 22-24. februar 2017. Book of Abstracts T4.2-2, pages 357-359. M63


    6. Газдић М, Симовић Марковић Б, Арсенијевић А, Јовичић Н, Ацовић A, Harrell CR, Арсенијевић Н, Лукић МЛ, Воларевић В. Интеракција мезенхималних матичних ћелија и регулаторних Т лимфоцита игра важну улогу у редукцији акутног оштећења јетре. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 3. M64


    7. Симовић Марковић Б, Газдић М, Арсенијевић А, Јовичић Н, Ђонов В, Арсенијевић Н, Лукић МЛ, Воларевић В. Примена мезенхималних матичних ћелија супримира акутно оштећење бубрега. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 4. M64


    8. Милосављевић Н, Газдић М, Симовић Марковић Б, Арсенијевић А, Јовичић Н, Ђонов В, Арсенијевић Н, Лукић МЛ, Воларевић В. Утицај мезенхималних матичних ћелија на сигнални пут il-17 у моделима акутног хепатитиса и фиброзе јетре. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 6. M64


    9. Јаковљевић Ј, Газдић М, Симовић Марковић Б, Арсенијевић А, Јовичић Н, Вучићевић Љ, Пауновић B, Мисиркић M, Арсенијевић H, Трајковић B, Воларевић B. Инхибиција аутофагије супримира хепатопротективне и имуномодулаторне карактеристике мезенхималних матичних ћелија у акутном хепатитису. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 7. M64


    10. Ацовић А, Симовић Марковић Б, Газдић М, Арсенијевић А, Јовичић Н, Гајовић Н, Јовановић И, Кањевац Т, Fellabaum С, Арсенијевић Н, Лукић МЛ, Воларевић В. Дендритске ћелије акивношћу индоламин 2, 3-диоксигеназе поспешују експанзију Т регулаторних ћелија у колону и доприносе регенерацији слузокоже црева оболелих од улцерозног колитиса. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 8. M64


    11. Ђоковић Б, Симовић Марковић Б, Газдић М, Јаковљевић Ј, Арсенијевић А, Јовичић Н, Арсенијевић Н, Лукић МЛ, Воларевић В. Делеција гена за gal-3 подстиче активацију дендритских ћелија поспешујући прогресију акутног оштећења бубрега. Светски дан имунологије-2018, Крагујевац, Србија, 26. април 2018. године књига сажетака (978-86-7760-124-9), страна 21. М64


    12. Газдић М, Симовић Марковић Б, Арсенијевић А, Јовичић Н, Арсенијевић Н, Лукић М, Воларевић B. Мезенхимске матичне ћелије супримирају фулминантни хепатитис подстичући експанзију и имуносупресивне карактеристике регулаторних Т лимфоцита у јетри. Светски дан имунологије-2019, Крагујевац, Србија, 23. април 2019. године књига сажетака (978-86-7760-134-8), страна 5. М64


    13. Симовић Марковић Б, Здравковић Н, Арсенијевић Н, Лукић М, Воларевић В. Галектин 3 подстиче кинуренин зависну интеракцију дендритских ћелија и Т регулаторних ћелија у хроничном колитису. Светски дан имунологије-2019, Крагујевац, Србија, 23. април 2019. године књига сажетака (978-86-7760-134-8), страна 18. М64


    14. Воларевић В, Симовић Марковић Б, Газдић Јанковић М, Ђоковић Б, Јовичић Н, Арсенијевић Н, Лукић М. Галектин 3 има протективну улогу у акутном оштећењу бубрега изазваног цисплатином. Светски дан имунологије-2019, Крагујевац, Србија, 23. април 2019. године књига сажетака (978-86-7760-134-8), страна 26. М64


    15. Ацовић А, Симовић Марковић Б, Газдић М, Арсенијевић А, Јовичић Н, Гајовић Н, Јовановић М, Здравковић Н, Кањевац Т, Арсенијевић Н, Лукић М, Воларевић В. Индоламин 2, 3-диоксигеназа повећава експанзију и број Т регулаторних ћелија у колону и на тај начин учествује у регенерацији слузокоже црева пацијената оболелих од улцерозног колитиса. Светски дан имунологије-2019, Крагујевац, Србија, 23. април 2019. године књига сажетака (978-86-7760-134-8), страна 29. М64


     
Poslednji put izmenjeno petak, 05 septembar 2025 10:31
Objavljeno u Medicinski fakultet
nazad na vrh

povratak na vrh strane

© Naučne publikacije akademskog osoblja 2025